HUMAN APOA-I VARIANTS

被引：0
|
作者：
Franceschini, G. [1 ]
机构：
[1] Univ Milan, Dept Pharmacol Sci, I-20122 Milan, Italy
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer
    Su, Feng
    Kozak, Kathy R.
    Imaizumi, Satoshi
    Gao, Feng
    Amneus, Malaika W.
    Grijalva, Victor
    Ng, Carey
    Wagner, Alan
    Hough, Greg
    Farias-Eisner, Gina
    Anantharamaiah, G. M.
    Van Lenten, Brian J.
    Navab, Mohamad
    Fogelman, Alan M.
    Reddy, Srinivasa T.
    Farias-Eisner, Robin
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (46) : 19997 - 20002
  • [32] MOLECULAR BEHAVIOR OF APOA-I IN HUMAN HIGH-DENSITY LIPOPROTEINS
    GWYNNE, J
    BREWER, HB
    EDELHOCH, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1975, 250 (06) : 2269 - 2274
  • [33] Characterization of Distal and Proximal Alternative Promoters of the Human ApoA-I Gene
    D. A. Mogilenko
    V. S. Shavva
    E. B. Dizhe
    S. V. Orlov
    Molecular Biology, 2019, 53 : 427 - 437
  • [34] ORIGIN AND SIGNIFICANCE OF THE MATURE APOA-I POLYMORPHISM IN HUMAN-PLASMA
    GHISELLI, G
    SHERRILL, BC
    TANENBAUM, S
    ROHDE, M
    GOTTO, AM
    CLINICAL RESEARCH, 1984, 32 (02): : A168 - A168
  • [35] Characterization of Distal and Proximal Alternative Promoters of the Human ApoA-I Gene
    Mogilenko, D. A.
    Shavva, V. S.
    Dizhe, E. B.
    Orlov, S. V.
    MOLECULAR BIOLOGY, 2019, 53 (03) : 427 - 437
  • [36] Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I (R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers
    Daum, U
    Leren, TP
    Langer, C
    Chirazi, A
    Cullen, P
    Pritchard, PH
    Assmann, G
    von Eckardstein, A
    JOURNAL OF LIPID RESEARCH, 1999, 40 (03) : 486 - 494
  • [37] HAPTOGLOBIN COPY NUMBER VARIANTS DO NOT DIMINISH THE EFFECT OF CSL112 (APOA-I [HUMAN]) ON HDL FUNCTION
    Duvalyan, Angela
    Gangwar, Anamika
    Kramer, Gerald
    Velkoska, Elena
    Greene, Brandon
    Duffy, Danielle
    Gibson, C. Michael
    Kingwell, Bronwyn
    Haley, Robert
    Rohatgi, Anand
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1209 - 1209
  • [38] INTERACTION OF RECONSTITUTED HIGH-DENSITY-LIPOPROTEIN DISKS CONTAINING HUMAN APOLIPOPROTEIN-A-I (APOA-I) VARIANTS WITH MURINE ADIPOCYTES AND MACROPHAGES - EVIDENCE FOR REDUCED CHOLESTEROL EFFLUX PROMOTION BY APOA-I(PRO165-]ARG)
    VONECKARDSTEIN, A
    CASTRO, G
    WYBRANSKA, I
    THERET, N
    DUCHATEAU, P
    DUVERGER, N
    FRUCHART, JC
    AILHAUD, G
    ASSMANN, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (04) : 2616 - 2622
  • [39] APOB, APOA-I VALUES AND APOB/APOA-I RATIO IN HYPERTENSIVE PATIENTS WITH NO CLINICAL SIGNS OF TARGET ORGAN DAMAGE
    Serban, C.
    Noveanu, L.
    Susan, L.
    Pacurari, A.
    Costea, C.
    Mateescu, R.
    Romosan, I.
    Cristescu, A.
    JOURNAL OF HYPERTENSION, 2010, 28 : E379 - E380
  • [40] Type 1 Deiodinase Regulates ApoA-I Gene Expression and ApoA-I Synthesis Independent of Thyroid Hormone Signaling
    Liu, Jing
    Hernandez-Ono, Antonio
    Graham, Mark J.
    Galton, Valerie Anne
    Ginsberg, Henry N.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (07) : 1356 - +
12345